Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1952 1
1953 1
1957 4
1958 3
1961 3
1962 2
1963 1
1964 10
1965 5
1966 2
1967 3
1968 2
1970 4
1971 5
1972 5
1973 4
1974 4
1975 5
1976 7
1977 14
1978 5
1979 7
1980 7
1981 4
1982 11
1983 11
1984 7
1985 17
1986 16
1987 16
1988 14
1989 11
1990 13
1991 14
1992 10
1993 12
1994 5
1995 22
1996 16
1997 14
1998 18
1999 13
2000 11
2001 29
2002 29
2003 29
2004 27
2005 31
2006 49
2007 68
2008 73
2009 81
2010 74
2011 78
2012 75
2013 88
2014 79
2015 64
2016 83
2017 85
2018 82
2019 66
2020 80
2021 90
2022 103
2023 80
2024 46
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,738 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, Yoneda M, Behling C, Cummings OW, Tang Y, Brouwers B, Robins DA, Nikooie A, Bunck MC, Haupt A, Sanyal AJ; SYNERGY-NASH Investigators. Loomba R, et al. Among authors: yoneda m. N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943. Epub 2024 Jun 8. N Engl J Med. 2024. PMID: 38856224 Clinical Trial.
Current and future pharmacological therapies for NAFLD/NASH.
Sumida Y, Yoneda M. Sumida Y, et al. Among authors: yoneda m. J Gastroenterol. 2018 Mar;53(3):362-376. doi: 10.1007/s00535-017-1415-1. Epub 2017 Dec 16. J Gastroenterol. 2018. PMID: 29247356 Free PMC article. Review.
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
Lin H, Lee HW, Yip TC, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Harrison SA, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KK, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gomez M, Kim SU, Wong VW; VCTE-Prognosis Study Group. Lin H, et al. Among authors: yoneda m. JAMA. 2024 Apr 16;331(15):1287-1297. doi: 10.1001/jama.2024.1447. JAMA. 2024. PMID: 38512249 Free PMC article.
Microbiota and nonalcoholic steatohepatitis.
Imajo K, Yoneda M, Ogawa Y, Wada K, Nakajima A. Imajo K, et al. Among authors: yoneda m. Semin Immunopathol. 2014 Jan;36(1):115-32. doi: 10.1007/s00281-013-0404-6. Epub 2013 Dec 14. Semin Immunopathol. 2014. PMID: 24337650 Review.
Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease.
Iwaki M, Kobayashi T, Nogami A, Saito S, Nakajima A, Yoneda M. Iwaki M, et al. Among authors: yoneda m. Nutrients. 2023 Feb 10;15(4):891. doi: 10.3390/nu15040891. Nutrients. 2023. PMID: 36839249 Free PMC article. Review.
Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.
Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, Honnorat J, Joubert B, Kakei S, Lee J, Manto M, Matsunaga A, Mizusawa H, Nanri K, Shanmugarajah P, Yoneda M, Yuki N. Mitoma H, et al. Among authors: yoneda m. Cerebellum. 2016 Apr;15(2):213-32. doi: 10.1007/s12311-015-0664-x. Cerebellum. 2016. PMID: 25823827 Free PMC article. Review.
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.
Mózes FE, Lee JA, Vali Y, Selvaraj EA, Jayaswal ANA, Boursier J, de Lédinghen V, Lupșor-Platon M, Yilmaz Y, Chan WK, Mahadeva S, Karlas T, Wiegand J, Shalimar, Tsochatzis E, Liguori A, Wong VW, Lee DH, Holleboom AG, van Dijk AM, Mak AL, Hagström H, Akbari C, Hirooka M, Lee DH, Kim W, Okanoue T, Shima T, Nakajima A, Yoneda M, Thuluvath PJ, Li F, Berzigotti A, Mendoza YP, Noureddin M, Truong E, Fournier-Poizat C, Geier A, Tuthill T, Yunis C, Anstee QM, Harrison SA, Bossuyt PM, Pavlides M. Mózes FE, et al. Among authors: yoneda m. Liver Int. 2024 Aug;44(8):1872-1885. doi: 10.1111/liv.15914. Epub 2024 Apr 4. Liver Int. 2024. PMID: 38573034 Free article.
Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease.
Nakatsuka T, Tateishi R, Sato M, Hashizume N, Kamada A, Nakano H, Kabeya Y, Yonezawa S, Irie R, Tsujikawa H, Sumida Y, Yoneda M, Akuta N, Kawaguchi T, Takahashi H, Eguchi Y, Seko Y, Itoh Y, Murakami E, Chayama K, Taniai M, Tokushige K, Okanoue T, Sakamoto M, Fujishiro M, Koike K. Nakatsuka T, et al. Among authors: yoneda m. Hepatology. 2024 May 20. doi: 10.1097/HEP.0000000000000904. Online ahead of print. Hepatology. 2024. PMID: 38768142
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD.
Kim BK, Tamaki N, Imajo K, Yoneda M, Sutter N, Jung J, Lin T, Tu XM, Bergstrom J, Nguyen K, Nguyen L, Le T, Madamba E, Richards L, Valasek MA, Behling C, Sirlin CB, Nakajima A, Loomba R. Kim BK, et al. Among authors: yoneda m. J Hepatol. 2022 Dec;77(6):1482-1490. doi: 10.1016/j.jhep.2022.07.020. Epub 2022 Aug 13. J Hepatol. 2022. PMID: 35973577
1,738 results